» Articles » PMID: 30787906

Broadening the Spectrum of Adulthood X-Linked Adrenoleukodystrophy: A Report of Two Atypical Cases

Overview
Journal Front Neurol
Specialty Neurology
Date 2019 Feb 22
PMID 30787906
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

X-linked adrenoleukodystrophy (x-ALD) is a rare genetic disorder caused by a mutation in the gene, which encodes for a peroxisomal very long chain fatty acid transporter. Clinically, x-ALD can present a wide spectrum of different phenotypes: asymptomatic carriers, Addison only, cerebral x-ALD, and myelopathy with/without evidence of peripheral axonopathy (Adrenomyeloneuropathy). We report on two cases of adult x-ALD, with atypical phenotypes: A 37-years-old male with a 2-years-long history of spastic paraparesis, urinary urgency, and subclinical adrenocortical insufficiency. As an atypical finding, the MRI showed multiple congenital brain development defects. A 63-years-old male with a previous diagnosis of Addison disease, with a 6-years-long history of spastic paraparesis. Two years later, he complained of severe and disabling burning pain in his feet. A nerve conduction study was normal, but a skin biopsy revealed autonomic and somatic small fiber neuropathy. In both cases, genetic testing disclosed hemizygous mutation in associated with x-ALD: c.1394-2A > G and p.(Thr254Met), respectively. While case 1 supports the key role of peroxisome functions in brain development, case 2 points to a possible selective and clinically relevant peripheral small fiber degeneration in x-ALD myelopathy.

Citing Articles

Age and gender-specific reference intervals for a panel of lysophosphatidylcholines estimated by tandem mass spectrometry in dried blood spots.

Natarajan A, Christopher R Pract Lab Med. 2023; 33:e00305.

PMID: 36618341 PMC: 9813575. DOI: 10.1016/j.plabm.2022.e00305.


Targeted Sequencing Detects Variants That May Contribute to the Risk of Neuropsychiatric Disorders.

Mahadevan J, Sud R, Nadella R, Vani P, Subramaniam A, Paul P Indian J Psychol Med. 2022; 44(5):516-522.

PMID: 36157006 PMC: 9460021. DOI: 10.1177/0253717621993672.


ABCD1 Gene Mutations: Mechanisms and Management of Adrenomyeloneuropathy.

Volmrich A, Cuenant L, Forghani I, Hsieh S, Shapiro L Appl Clin Genet. 2022; 15:111-123.

PMID: 35983253 PMC: 9381027. DOI: 10.2147/TACG.S359479.


Ocular findings and genomics of X-linked recessive disorders: A review.

Hassan A, Mir Y, Kuchay R Indian J Ophthalmol. 2022; 70(7):2386-2396.

PMID: 35791118 PMC: 9426149. DOI: 10.4103/ijo.IJO_252_22.


Pain Study in X-Linked Adrenoleukodystrophy in Males and Females.

Bachiocco V, Cappa M, Petroni A, Salsano E, Bizzarri C, Ceccarelli I Pain Ther. 2021; 10(1):505-523.

PMID: 33609269 PMC: 8119579. DOI: 10.1007/s40122-021-00245-0.

References
1.
Herrmann D, Griffin J, Hauer P, Cornblath D, McArthur J . Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology. 1999; 53(8):1634-40. DOI: 10.1212/wnl.53.8.1634. View

2.
van Geel B, Bezman L, Loes D, Moser H, Raymond G . Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol. 2001; 49(2):186-94. DOI: 10.1002/1531-8249(20010201)49:2<186::aid-ana38>3.0.co;2-r. View

3.
Dubey P, Raymond G, Moser A, Kharkar S, Bezman L, Moser H . Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. J Pediatr. 2005; 146(4):528-32. DOI: 10.1016/j.jpeds.2004.10.067. View

4.
Lauria G, Cornblath D, Johansson O, McArthur J, Mellgren S, Nolano M . EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol. 2005; 12(10):747-58. DOI: 10.1111/j.1468-1331.2005.01260.x. View

5.
Ferdinandusse S, Ylianttila M, Gloerich J, Koski M, Oostheim W, Waterham H . Mutational spectrum of D-bifunctional protein deficiency and structure-based genotype-phenotype analysis. Am J Hum Genet. 2005; 78(1):112-24. PMC: 1380208. DOI: 10.1086/498880. View